Latest Industry Insights

In this interview, Dr. Tabitha Bullock tells us about some of the key considerations in cell line development and how advances in technology are improving the efficiency and productivity of cell lines.

A new method to biofortify pea shoots with vitamin B12 could tackle deficiency issues. In this interview with Technology Networks, Professor Antony Dodd, head of cell and developmental biology at the John Innes Centre, explains why.

Sustainability is an important area of focus for modern laboratory operations. In this article, Tarun Anumol, PhD, Global Environment Market Director at Agilent Technologies discusses sustainability in environmental testing labs.

In this interview, Technology Networks spoke to Heiko Neuweger, director of Bioinformatics Life Science Mass Spectrometry Software R&D at Bruker, to learn about the importance of target compound annotation and identification, the advantages of integrating collision cross section (CCS) information into workflows and the benefits of CCS-Predict Pro.

In this interview, Dr. Lorna De Leoz, global food segment director at Agilent Technologies, highlights practical advice to make a food and beverage lab more sustainable. She also discusses the role of metrics when establishing sustainability goals and how vendors can work with labs to ensure they achieve these goals.

This article looks at the technologies currently being developed that can help to identify patients with a higher risk of prostate cancer, ultimately reducing the number of unnecessary biopsies.

Andrew Schulman explores why we need allogeneic therapies, the importance of collaboration to keep the momentum, and challenges and predictions for the future.

Technology Networks spoke to Dr. Markus Gershater to learn more about Synthace's Lab automation & experimentation in life science R&D 2023-2024 report, its findings and their significance.

Join us for an interview with HP's Christie Dudenhoefer, manager of Life Science Solutions, and Dr. Ryan Kelly, professor in the Department of Chemistry at Brigham Young University, to learn how HP's D100 single-cell dispenser is being utilized.

Technology Networks spoke to the CEO of the Novo Nordisk Foundation Cellerator, Dr. Thomas H.R. Carlsen, to find out more about their new world-class facility that will focus on upscaling cell therapy development.